🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Gliflozins have demonstrated a beneficial effect in terms of incident heart...
Status
Unknown
Location
Pitié-Salpêtrière Hospital
Start Date
2022-06-26
Trial ID
NCT05420285
Treatments Being Tested
Background. Treatment with intravenous iron has been shown to improve sympt...
Status
Not Yet Recruiting
Location
Hospital de Clínicas de Porto Alegre
Start Date
2024-05-24
Trial ID
NCT06434025
The purpose of the study is to assess the effects of rifampin on the pharma...
Status
Terminated
Location
Ppd Development
Start Date
2010-03
Trial ID
NCT01068756
Treatments Being Tested
There are approximately 400,000 people in the UK who are living with type 1...
Status
Terminated
Location
Clinical Research Unit, OCDEM, Churchill Hospital
Start Date
2018-06-02
Trial ID
NCT03537131
Treatments Being Tested
This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Status
Completed
Location
Research Site
Start Date
2018-02-28
Trial ID
NCT03387683
Treatments Being Tested
The DAPA-HF trial demonstrated that dapagliflozin was able to reduce the ri...
Status
Completed
Location
Cheng Hsin General Hospital
Start Date
2020-05-29
Trial ID
NCT04575675
The goal of this clinical trial is to evaluate the short-term clinical outc...
Status
Completed
Location
Aswan Heart Centre
Start Date
2023-08-01
Trial ID
NCT06012279
Treatments Being Tested
This is an international, multicentre, parallel-group, event-driven, random...
Status
Completed
Location
Research Site
Start Date
2018-08-27
Trial ID
NCT03619213
Treatments Being Tested
The purpose of this study is to determine whether treatment with Dapagliflo...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2021-02-24
Trial ID
NCT04730947
Treatments Being Tested
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested